DVA
What one share of Davita holds
Services – Misc Health and Allied Services, NEC
DaVita is a leading healthcare provider focused on transforming care delivery to improve quality of life for patients globally. As a comprehensive kidney care provider, we have been a leader in clinical quality and innovation for more than 25 years.
Davita’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $200.23 |
|---|---|
| Profit | $12.11 |
| Capex (buildings and equipment) | $8.34 |
| Free cash flow | $23.01 |
| Cash and investments | $11.37 |
| Debt | $168.57 |
| Book value | −$11.96 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | $52.26 | $4.29 | $4.05 | $5.58 | — | $23.89 |
| 2017 | $56.84 | $3.47 | $4.73 | $5.27 | — | $25.70 |
| 2018 | $66.17 | $0.92 | $5.73 | $4.55 | — | $22.26 |
| 2019 | $74.04 | $5.27 | $4.98 | $8.49 | — | $16.95 |
| 2020 | $94.20 | $6.31 | $5.50 | $10.64 | — | $12.59 |
| 2021 | $105.68 | $8.90 | $5.83 | $11.73 | — | $7.77 |
| 2022 | $121.15 | $5.85 | $6.30 | $10.03 | — | $7.88 |
| 2023 | $130.28 | $7.42 | $6.10 | $16.00 | — | $11.89 |
| 2024 | $146.84 | $10.73 | $6.36 | $16.80 | — | $1.50 |
| 2025 | $179.79 | $9.84 | $7.59 | $17.27 | — | −$9.50 |